Mr. Sebastià Videla Cés, MD PhD, is a clinical pharmacologist, Head of Clinical Research Department-IDIBELL at the Clinical Pharmacology Department in Bellvitge University Hospital, in Barcelona, Spain. He is a lecturer (tenure-track 2 lecturer), Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, University of Barcelona. He has worked in clinical research in pain areas during the last 25 years (clinical trials and observational studies), and he has been the person in charge of a new painkiller development (currently, in the marketing authorization process).
Mr. Sebastià Videla Cés, MD PhD, is a clinical pharmacologist, Head of Clinical Research Department-IDIBELL at the Clinical Pharmacology Department in Bellvitge University Hospital, in Barcelona, Spain. He is a lecturer (tenure-track 2 lecturer), Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, University of Barcelona. He has worked in clinical research in pain areas during the last 25 years (clinical trials and observational studies), and he has been the person in charge of a new painkiller development (currently, in the marketing authorization process).